Universitätsklinikum Bonn

TFAP2E is implicated in central nervous system, orofacial and maxillofacial anomalies. (2025) Kalanithy JC, Mingardo E, Stegmann JD, Dhakar R, Dakal TC, Rosenfeld JA, Tan WH, et al. Journal article Multimodal Profiling of Peripheral Blood Identifies Proliferating Circulating Effector CD4+ T Cells as Predictors for Response to Integrin α4β7-Blocking Therapy in Inflammatory Bowel Disease. (2025) Horn V, Cancino CA, Steinheuer LM, Obermayer B, Fritz K, Nguyen AL, Juhran KS, et al. Journal article Trio Exome Sequencing in VACTERL Association (2025) Ćomić J, Tilch E, Riedhammer KM, Brugger M, Brunet T, Eyring K, Vill K, et al. Journal article Idecabtagene vicleucel or ciltacabtagene autoleucel for relapsed or refractory multiple myeloma: An international multicenter study (2025) Merz M, Albici AM, von Tresckow B, Rathje K, Fenk R, Holderried T, Müller F, et al. Journal article Psychological and Social Factors Associated With Reporting Post-COVID Symptoms Among German Healthcare Workers: A Cross-Sectional Study (2025) Schick V, Lieb M, Borho A, Morawa E, Geiser F, Beschoner P, Jerg-Bretzke L, et al. Journal article The modified Glasgow Prognostic Score (mGPS) can guide decisions for immunotherapy treatment beyond progression. (2025) Saal J, Eckstein M, Ritter M, Brossart P, Hölzel M, Grünwald V, Klümper N Journal article Immunogenetics of lithium response and psychiatric phenotypes in patients with bipolar disorder (2024) Herrera-Rivero M, Gutiérrez-Fragoso K, Kurtz J, Baune BT, Thalamuthu A, Amare AT, Adli M, et al. Journal article Exploring the genetics of lithium response in bipolar disorders (2024) Herrera-Rivero M, Adli M, Akiyama K, Akula N, Amare AT, Ardau R, Arias B, et al. Journal article Group 2 innate lymphoid cells are a non-redundant source of interleukin-5 required for development and function of murine B1 cells (2024) Troch KF, Jakob MO, Forster PM, Jarick KJ, Schreiber J, Preusser A, Guerra GM, et al. Journal article Bispecific antibodies targeting BCMA or GPRC5D are highly effective in relapsed myeloma after CAR T-cell therapy (2024) Merz M, Dima D, Hashmi H, Ahmed N, Stölzel F, Holderried TA, Fenk R, et al. Journal article